“Being diagnosed with MS triggers a host of emotional reactions and uncertainties. The psychological impact that MS has on you and your family is massively underestimated.”
“The paper below tries to review the evidence of using a strengths based approaches to help families manage the uncertainty associated with a progressive neurological disease such as MS. The review clearly highlights the need for more work in this area.”
“In my sociology course at medical school we learnt about Helen Kübler-Ross’s five stages of grief, best known by the acronym DABDA (Denial, Anger, Bargaining, Depression and Acceptance). For those of you with relapse-onset disease, not only do you have to go through these stages when you are diagnosed with MS, but you go through them again when you enter the secondary progressive phase of the disease. In addition, many family members experience the same emotional stages by proxy. MS is a double-disease; it hits you a second time when, and if, you enter the clinically apparent secondary progressive phase of the disease!”
“The realisation that you have either missed out on DMTs, or that the DMTs have failed, leads to the re-emergence of grief and the five emotional stages that go with it. The anger you experience is more often than not directed at the medical team for being impotent to stop the disease; exposing unrealistic expectations, which were made to give you hope. As a result of being an outspoken critic of therapeutic nihilism – the blight of our profession – a proponent of early effective treatment and the holistic management of MS, I seem to take a lot of flak. Managing MS can be emotionally exhausting! For example, I saw a new patient this week who despite having very active MS and having being advised by several neurologists to start DMTs, and didn’t. She now presents with progressive unsteadiness of gait and weakness in her lower limbs. When I explained to her and her husband that she has now entered the SP phase of MS and that she was unlikely to benefit very much from the licensed DMTs, she was very, very, upset. She had just been rediagnosed with MS, only this time SPMS with all the negativity that goes with this stage of the disease. I could see her beginning to go through the emotional stages again; DABDA.”
“As a pwMS you need to know about the stages of grief and recognise your emotional reactions to the diagnosis and the onset of the progressive phase of the disease. The truth is we don’t have any therapies to stop or slow disease progression at present, but we are working on it. Ocrelizumab is just around the corner for PPMS and there are other progressive trials running at present. If you have symptoms that are impacting on your quality of life we can help. You would be amazed at what a difference effective symptomatic treatments can make to your life.”
“Finally, I we would like to add an extra A onto DABDA for MSers, ie. DABDAA. The extra A is for anxiety. The uncertainty that a comes with a diagnosis of MS is usually not appreciated enough. If you need help coping with anxiety or any of the other emotions mentioned above please speak to your medical team.”
Tams et al. Helping families thrive in the face of uncertainty: Strengths based approaches to working with families affected by progressive neurological illness. NeuroRehabilitation. 2016 Mar 23.
OBJECTIVE: To undertake a systematic review of the evidence on the use of strengths based, family focused interventions that target illness uncertainty.
METHODS: A systematic literature search was undertaken using the National Library for Health abstract database.
RESULTS: Five papers were included in the review, only two of which were published in peer reviewed journals. All five reported on strengths based approaches that could be used with families but only two explicitly identified illness uncertainty as a target. Outcome measures were heterogeneous so data could not be aggregated for meta-analysis. The results suggested that these interventions showed promised but the review highlighted a number of methodological issues which mean that the results must be interpreted with caution.
CONCLUSIONS: There is very little evidence of the use of strengths based approaches to helping families manage the uncertainty associated with progressive neurological illness despite it having been identified as a key target for intervention. The review highlights the need for the development of an intervention framework to address this key clinical issue and suggests one model that might show promise.